Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Gastric Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 70 articles: HTML format

Single Articles

March 2008
1. PARK SR , Kim HK, Kim CG, Choi IJ, et al
   Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. WEI J , Zou Z, Qian X, Ding Y, et al
   ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. KUBOTA T
   The role of S-1 in the treatment of gastric cancer.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. GOROUHI F , Islami F, Bahrami H, Kamangar F, et al
   Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
5. LEE MK , Lee KM, Bae JM, Kim S, et al
   Employment status and work-related difficulties in stomach cancer survivors compared with the general population.
   Br J Cancer. 2008;98:708-15.
   PubMed     Related articles    Abstract available
   
   
   
6. GRIFFITHS EA , Pritchard SA, McGrath SM, Valentine HR, et al
   Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. OTSUBO T , Akiyama Y, Yanagihara K, Yuasa Y, et al
   SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
8. KANG HJ , Chang HM, Kim TW, Ryu MH, et al
   A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.
   Br J Cancer. 2008;98:316-22.
   PubMed     Related articles    Abstract available
   
   
   
9. MATSUBARA J , Nishina T, Yamada Y, Moriwaki T, et al
   Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. KIM JG , Sohn SK, Chae YS, Song HS, et al
    Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. WU CW , Chiou JM, Ko FS, Lo SS, et al
    Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial.
    Br J Cancer. 2008;98:54-9.
    PubMed     Related articles    Abstract available
    
    
    
12. KATSURAGI K , Yashiro M, Hirakawa K
    Reply: Identification of isolated tumour cells by detection of CEA and CK mRNA in peritoneal lavage fluid of gastric cancer patients.
    Br J Cancer. 2008;.
    PubMed     Related articles   
    
    
    
13. DEANS DA , Wigmore SJ, Gilmour H, Tisdale MJ, et al
    Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.
    Br J Cancer. 2008;98:243.
    PubMed     Related articles   
    
    
    December 2007
14. MIZUKAMI Y , Kono K, Kawaguchi Y, Akaike H, et al
    Localisation pattern of Foxp3(+) regulatory T cells is associated with clinical behaviour in gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. SHODA H , Kakugawa Y, Saito D, Kozu T, et al
    Evaluation of (18)F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy.
    Br J Cancer. 2007;97:1493-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
16. KOSHIOL J , Qiao YL, Mark SD, Dawsey SM, et al
    Epstein-Barr virus serology and gastric cancer incidence and survival.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
17. ROSERO-BIXBY L , Sierra R
    X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica.
    Br J Cancer. 2007;97:837-43.
    PubMed     Related articles    Abstract available
    
    
    
18. VAN VLIET EP , Steyerberg EW, Eijkemans MJ, Kuipers EJ, et al
    Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis.
    Br J Cancer. 2007;97:868-76.
    PubMed     Related articles    Abstract available
    
    
    
19. SUTTIE SA , Park KG, Smith TA
    [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil.
    Br J Cancer. 2007;97:902-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
20. TAKAYAMA T , Sato Y, Sagawa T, Okamoto T, et al
    Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. CHENG YY , Yu J, Wong YP, Man EP, et al
    Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. JANSEN EP , Boot H, Dubbelman R, Bartelink H, et al
    Postoperative chemoradiotherapy in gastric cancer - a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
    Br J Cancer. 2007;97:712-6.
    PubMed     Related articles    Abstract available
    
    
    
23. DI LAURO L , Nunziata C, Arena MG, Foggi P, et al
    Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2007;97:593-7.
    PubMed     Related articles    Abstract available
    
    
    August 2007
24. KOLODZIEJCZYK P , Pituch-Noworolska A, Drabik G, Kulig J, et al
    The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
25. KATSURAGI K , Yashiro M, Sawada T, Osaka H, et al
    Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. JEUNG HC , Rha SY, Shin SJ, Ahn JB, et al
    A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. NAKAMURA Y , Tanaka F, Haraguchi N, Mimori K, et al
    Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. HAWINKELS LJ , Verspaget HW, van Duijn W, van der Zon JM, et al
    Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. SUNG NY , Choi KS, Park EC, Park K, et al
    Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. CHEN CC , Chen LT, Tsou TC, Pan WY, et al
    Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
31. YAMANAKA T , Matsumoto S, Teramukai S, Ishiwata R, et al
    Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. CHEN W , Dawsey SM, Qiao YL, Mark SD, et al
    Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. VAN BLANKENSTEIN M , Looman CW, Siersema PD, Kuipers EJ, et al
    Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989-2003.
    Br J Cancer. 2007;96:1767-71.
    PubMed     Related articles    Abstract available
    
    
    May 2007
34. EL-ZAATARI M , Tobias A, Grabowska AM, Kumari R, et al
    De-regulation of the sonic hedgehog pathway in the InsGas mouse model of gastric carcinogenesis.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. KOSAKA Y , Mimori K, Fukagawa T, Ishikawa K, et al
    Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. VAN MEERTEN E , Eskens FA, van Gameren EC, Doorn L, et al
    First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.
    Br J Cancer. 2007;96:1348-52.
    PubMed     Related articles    Abstract available
    
    
    
37. OH SC , Sur HY, Sung HJ, Choi IK, et al
    A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
38. HEMMINKI K , Sundquist J, Ji J
    Familial risk for gastric carcinoma: an updated study from Sweden.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. KIM JS , Chung SJ, Choi YS, Cheon JH, et al
    Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
40. NERI B , Pantaleo P, Giommoni E, Grifoni R, et al
    Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
41. TAJIMA Y , Yamazaki K, Makino R, Nishino N, et al
    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
    Br J Cancer. 2007;96:631-8.
    PubMed     Related articles    Abstract available
    
    
    January 2007
42. NODA H , Miyaji Y, Nakanishi A, Konishi F, et al
    Frequent reduced expression of alpha-1B-adrenergic receptor caused by aberrant promoter methylation in gastric cancers.
    Br J Cancer. 2007;96:383-90.
    PubMed     Related articles    Abstract available
    
    
    
43. FEATHERSTONE C , Colley A, Tucker K, Kirk J, et al
    Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence.
    Br J Cancer. 2007;96:391-8.
    PubMed     Related articles    Abstract available
    
    
    
44. KAMOSHIDA S , Suzuki M, Shimomura R, Sakurai Y, et al
    Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
45. KAMANGAR F , Qiao YL, Blaser MJ, Sun XD, et al
    Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
46. GRIFFITHS EA , Pritchard SA, Valentine HR, Whitchelo N, et al
    Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
47. HASUO T , Semba S, Li D, Omori Y, et al
    Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
48. DEANS DA , Wigmore SJ, Gilmour H, Paterson-Brown S, et al
    Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer.
    Br J Cancer. 2006;95:1568-75.
    PubMed     Related articles    Abstract available
    
    
    November 2006
49. MOCHIKI E , Ohno T, Kamiyama Y, Aihara R, et al
    Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
50. YOKOYAMA H , Ikehara Y, Kodera Y, Ikehara S, et al
    Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2006
51. ZHENG HC , Takahashi H, Murai Y, Cui ZG, et al
    Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
52. LEIGH Y , Seagroatt V, Goldacre M, McCulloch P, et al
    Impact of socio-economic deprivation on death rates after surgery for upper gastrointestinal tract cancer.
    Br J Cancer. 2006;95:940-3.
    PubMed     Related articles    Abstract available
    
    
    August 2006
53. KUBBEN FJ , Sier CF, Meijer MJ, van den Berg M, et al
    Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
54. FALK S , Anthoney A, Eatock M, Van Cutsem E, et al
    Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2006;95:450-6.
    PubMed     Related articles    Abstract available
    
    
    
55. GWACK J , Shin A, Kim CS, Ko KP, et al
    CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
56. JENAB M , Riboli E, Ferrari P, Friesen M, et al
    Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition.
    Br J Cancer. 2006;95:406-15.
    PubMed     Related articles    Abstract available
    
    
    
57. SCARTOZZI M , Galizia E, Verdecchia L, Berardi R, et al
    Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    June 2006
58. CHAO Y , Li CP, Chao TY, Su WC, et al
    An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
59. YAMAGUCHI K , Shimamura T, Hyodo I, Koizumi W, et al
    Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.
    Br J Cancer. 2006;94:1803-8.
    PubMed     Related articles    Abstract available
    
    
    
60. CHANDANOS E , Lindblad M, Jia C, Rubio CA, et al
    Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
61. CRUMLEY AB , McMillan DC, McKernan M, Going JJ, et al
    An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer.
    Br J Cancer. 2006;94:1568-71.
    PubMed     Related articles    Abstract available
    
    
    May 2006
62. MIMORI K , Sadanaga N, Yoshikawa Y, Ishikawa K, et al
    Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
63. BURGE ME , Smith D, Topham C, Jackson DP, et al
    A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.
    Br J Cancer. 2006;94:1281-6.
    PubMed     Related articles    Abstract available
    
    
    April 2006
64. BAEK JH , Kim JG, Jeon SB, Chae YS, et al
    Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
65. PARK SR , Chun JH, Yu MS, Lee JH, et al
    Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
66. INOKUCHI M , Yamashita T, Yamada H, Kojima K, et al
    Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. PARK YH , Kim BS, Ryoo BY, Yang SH, et al
    A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
68. LEYDEN J , Murray D, Moss A, Arumuguma M, et al
    Net1 and Myeov: computationally identified mediators of gastric cancer.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
69. DEANS DA , Wigmore SJ, Gilmour H, Tisdale MJ, et al
    Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.
    Br J Cancer. 2006;94:731-6.
    PubMed     Related articles    Abstract available
    
    
    
70. CRUMLEY AB , McMillan DC, McKernan M, McDonald AC, et al
    Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.
    Br J Cancer. 2006;94:637-41.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: